4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Associations of maternal phthalate and bisphenol urine concentrations during pregnancy with childhood blood pressure in a population-based prospective cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives:

          Fetal exposure to phthalates and bisphenols may lead to vascular developmental adaptations, which program later cardiovascular disease. We examined the associations of fetal exposure to phthalates and bisphenols with childhood blood pressure.

          Methods:

          In a population-based, prospective cohort study among 1,064 mother-child pairs, we measured maternal urine phthalate and bisphenol concentrations in first, second and third trimester of pregnancy. We measured childhood blood pressure at the mean age of 9.7 years (standard deviation 0.2 years) old. Analyses were performed for the total group, and for boys and girls separately.

          Results:

          Maternal urine phthalate concentrations were not associated with childhood blood pressure among boys. Higher third trimester maternal urine concentrations of high molecular weight phthalates (HMWP), di-2-ehtylhexylphthalate (DEHP) and di-n-octylphthalate (DNOP) were associated with lower systolic and diastolic blood pressure among girls (p-values < 0.01). Also, higher second trimester maternal urine total bisphenol and bisphenol A concentrations were associated with higher systolic blood pressure among boys (p values < 0.01), but tended to be associated with a lower diastolic blood pressure among girls.

          Conclusions:

          Our results suggest sex-dependent associations of maternal urine phthalate and bisphenol concentrations during pregnancy with childhood blood pressure. Further studies are needed to explore the underlying mechanisms and long term consequences.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: not found
          • Article: not found

          Estimation of Average Concentration in the Presence of Nondetectable Values

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human exposure to phthalates via consumer products.

            Phthalate exposures in the general population and in subpopulations are ubiquitous and widely variable. Many consumer products contain specific members of this family of chemicals, including building materials, household furnishings, clothing, cosmetics, pharmaceuticals, nutritional supplements, medical devices, dentures, children's toys, glow sticks, modelling clay, food packaging, automobiles, lubricants, waxes, cleaning materials and insecticides. Consumer products containing phthalates can result in human exposures through direct contact and use, indirectly through leaching into other products, or general environmental contamination. Historically, the diet has been considered the major source of phthalate exposure in the general population, but all sources, pathways, and their relative contributions to human exposures are not well understood. Medical devices containing di-(2-ethylhexyl) phthalate are a source of significant exposure in a susceptible subpopulation of individuals. Cosmetics, personal care products, pharmaceuticals, nutritional supplements, herbal remedies and insecticides, may result in significant but poorly quantified human exposures to dibutyl phthalate, diethyl phthalate, or dimethyl phthalate. Oven baking of polymer clays may cause short-term, high-level inhalation exposures to higher molecular weight phthalates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Molecular and cellular basis of cardiovascular gender differences.

              Cardiovascular diseases (CVDs), the major cause of morbidity and mortality for both men and women, occur uncommonly in premenopausal women, but their incidence rises sharply after the menopausal transition. Cardiovascular gender differences are apparent long before CVDs appear in men and women, and improved understanding of the biology underlying these differences has the potential to advance the diagnosis and treatment of CVDs in both sexes. This review considers gender differences in the molecular and cellular physiology of the heart and blood vessels in health and disease, highlighting understudied areas that can help resolve the current controversy regarding hormone replacement therapy and improve cardiovascular health in women.
                Bookmark

                Author and article information

                Journal
                7807270
                22115
                Environ Int
                Environ Int
                Environment international
                0160-4120
                1873-6750
                22 June 2020
                25 March 2020
                May 2020
                12 July 2020
                : 138
                : 105677
                Affiliations
                [a ]The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
                [b ]Department of Paediatrics, Erasmus MC – Sophia Children’s Hospital, University Medical Center Rotterdam, Rotterdam, the Netherlands
                [c ]Wadsworth Center, New York State Department of Health, and Department of Environmental Health Sciences, School of Public Health, State University of New York at Albany, Albany, NY 12201, USA
                [d ]Department of Chemistry, the Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway
                [e ]Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
                [f ]Department of Paediatrics, New York University School of Medicine, New York City, NY 10016, USA
                [g ]Department of Environmental Medicine, New York University School of Medicine, New York City, NY 10016, USA
                [h ]Department of Population Health, New York University School of Medicine, New York City, NY, USA
                [i ]New York University Wagner School of Public Service, New York City, NY 10016, USA
                [j ]New York University College of Global Public Health, New York City, NY 10016, USA
                Author notes
                [1]

                These authors contributed equally to this work.

                CRediT authorship contribution statement

                Chalana M. Sol: Methodology, Formal analysis, Writing - original draft. Susana Santos: Methodology, Formal analysis, Writing - original draft. Alexandros G. Asimakopoulos: Investigation, Writing - review & editing. Maria-Pilar Martinez-Moral: Investigation, Writing - review & editing. Liesbeth Duijts: Writing - review & editing. Kurunthachalam Kannan: Investigation, Writing - review & editing. Leonardo Trasande: Conceptualization, Resources, Supervision, Funding acquisition, Writing - review & editing. Vincent W.V. Jaddoe: Conceptualization, Resources, Supervision, Funding acquisition, Writing - review & editing.

                [* ]Corresponding author at: The Generation R Study Group (Na 29-08), Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands., v.jaddoe@ 123456erasmusmc.nl (V.W.V. Jaddoe).
                Article
                NIHMS1606061
                10.1016/j.envint.2020.105677
                7354351
                32220816
                dbdcbf29-cc56-453c-bdd4-6f57d8c65969

                This is an open access article under the CC BY license ( http://creativecommons.org/licenses/BY/4.0/).

                History
                Categories
                Article

                endocrine disruptor,phthalate,bisphenol,pregnancy,blood pressure

                Comments

                Comment on this article